Skip to main content
. 2022 May 21;10(5):817. doi: 10.3390/vaccines10050817

Figure 1.

Figure 1

(A)—RBD-specific IgG titers in vaccinated individuals, median and 95% CI; (B)—NtAb titers against SARS-CoV-2 B.1 in vaccinated individuals, geometric mean titer and 95% CI, C, D—NtAb titers against SARS-CoV-2 B.1 (Wuhan D614G) and B.1.1.529 (Omicron) variants in Sputnik V- (C) and BNT162b2 (D)-vaccinated individuals, geometric mean titer and 95% CI, %—part of sera with detectable NtAb. p-value was determined by Wilcoxon test. Grey box—limit of detection. Values below the limit of detection were assigned a value of NtAb 1.25.